AWM
GILD icon

Abound Wealth Management’s Gilead Sciences GILD Stock Holding History

Abound Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.94K Sell
63
-135
-68% -$17.8K ﹤0.01% 520
2026
Q1 		$27.6K Buy
198
+20
+11% +$2.8K 0.01% 337
2025
Q4 		$21.8K Buy
178
+6
+3% +$729 0.01% 346
2025
Q3 		$19.1K Hold
172
– – ﹤0.01% 365
2025
Q2 		$19K Buy
172
+26
+18% +$2.77K 0.01% 339
2025
Q1 		$16.3K Sell
146
-49
-25% -$5.06K 0.01% 331
2024
Q4 		$18K Sell
195
-170
-47% -$15.3K 0.01% 295
2024
Q3 		$30.6K Buy
365
+183
+101% +$14K 0.01% 227
2024
Q2 		$12.5K Sell
182
-25
-12% -$1.67K ﹤0.01% 331
2024
Q1 		$15.2K Sell
207
-38
-16% -$2.92K 0.01% 301
2023
Q4 		$19.8K Buy
245
+45
+23% +$3.5K 0.01% 264
2023
Q3 		$15K Buy
200
+2
+1% +$154 0.01% 263
2023
Q2 		$15.3K Buy
198
+31
+19% +$2.47K 0.01% 265
2023
Q1 		$13.9K Buy
167
+28
+20% +$2.32K 0.01% 249
2022
Q4 		$11.9K Buy
139
+42
+43% +$3.33K 0.01% 240
2022
Q3 		$6K Buy
+97
New +$6.12K ﹤0.01% 340

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Abound Wealth Management's GILD Position: Q2 2026 in Review

Abound Wealth Management reduced its Gilead Sciences (GILD) stake by 68% in Q2 2026, selling an estimated $17.8K and leaving 63 shares worth $7.94K. The position accounts for ﹤0.01% of the portfolio, ranked #520.

Abound Wealth Management first reported a position in GILD in Q3 2022 and has held it in 16 quarters since. The position peaked at $30.6K in Q3 2024. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Abound Wealth Management held 63 shares of Gilead Sciences worth $7.94K as of Q2 2026.
  • Abound Wealth Management sold 135 Gilead Sciences shares in Q2 2026, an estimated $17.8K.
  • Gilead Sciences made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #520 holding.
  • Abound Wealth Management first reported a position in Gilead Sciences in Q3 2022 and has held it in 16 quarters since.
  • Abound Wealth Management's Gilead Sciences position peaked at $30.6K in Q3 2024.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.